Difference between revisions of "Actin (TG2)"
m |
|||
Line 1: | Line 1: | ||
− | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | + | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" {{infobox header}}| '''{{PAGENAME}}''' |
− | |||
|- | |- | ||
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:Actin.JPG|200px|{{PAGENAME}}]] | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Actin.JPG|200px|{{PAGENAME}}]] | ||
Line 51: | Line 50: | ||
|{{#ev:youtube|y4WT_bMcQEs|300}} | |{{#ev:youtube|y4WT_bMcQEs|300}} | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] |
Latest revision as of 10:23, 10 March 2015
Substrate peptide name | Actin |
Synonyms | - |
Determination type | In situ |
Source | Homo sapiens |
Subcellular localization | Cytoskeleton |
Swissprot ID | P60709 |
Reactive glutamines | Q41 |
Reactive lysines | K113 |
Substrate sequence | GRPRHQGVMVG
APLNPKANREK |
Structure | 2BTF |
Surface accessibility | ASAView (pdf)
ASAView (txt) |
Disorder prediction | IUPred |
Reference | PMID:9252372 |
Notes | |
Video | y4WT_bMcQEs|300}} |